Revance Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Revance Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2014 to Q3 2024.
  • Revance Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 418 %, a 11.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 418 -54.4 -11.5% Sep 30, 2024
Q2 2024 433 -59.9 -12.1% Jun 30, 2024
Q1 2024 470 +19.9 +4.42% Mar 31, 2024
Q4 2023 442 -5.55 -1.24% Dec 31, 2023
Q3 2023 473 +56.7 +13.6% Sep 30, 2023
Q2 2023 493 +107 +27.8% Jun 30, 2023
Q1 2023 450 +0.13 +0.03% Mar 31, 2023
Q4 2022 447 -89.6 -16.7% Dec 31, 2022
Q3 2022 416 -222 -34.8% Sep 30, 2022
Q2 2022 386 -325 -45.7% Jun 30, 2022
Q1 2022 450 -360 -44.5% Mar 31, 2022
Q4 2021 537 -360 -40.1% Dec 31, 2021
Q3 2021 638 -272 -29.9% Sep 30, 2021
Q2 2021 711 -223 -23.9% Jun 30, 2021
Q1 2021 810 +13.6 +1.7% Mar 31, 2021
Q4 2020 897 +218 +32.2% Dec 31, 2020
Q3 2020 910 +251 +38% Sep 30, 2020
Q2 2020 934 +267 +40% Jun 30, 2020
Q1 2020 796 +48.1 +6.43% Mar 31, 2020
Q4 2019 678 -138 -16.9% Dec 31, 2019
Q3 2019 659 -319 -32.6% Sep 30, 2019
Q2 2019 667 -355 -34.7% Jun 30, 2019
Q1 2019 748 -270 -26.5% Mar 31, 2019
Q4 2018 817 -103 -11.2% Dec 31, 2018
Q3 2018 978 +151 +18.2% Sep 30, 2018
Q2 2018 1.02K +92.7 +9.97% Jun 30, 2018
Q1 2018 1.02K -99.8 -8.93% Mar 31, 2018
Q4 2017 920 -474 -34% Dec 31, 2017
Q3 2017 827 -877 -51.5% Sep 30, 2017
Q2 2017 930 -844 -47.6% Jun 30, 2017
Q1 2017 1.12K -548 -32.9% Mar 31, 2017
Q4 2016 1.39K -316 -18.5% Dec 31, 2016
Q3 2016 1.7K +125 +7.89% Sep 30, 2016
Q2 2016 1.77K +194 +12.3% Jun 30, 2016
Q1 2016 1.67K +219 +15.1% Mar 31, 2016
Q4 2015 1.71K +714 +71.6% Dec 31, 2015
Q3 2015 1.58K +1.1K +232% Sep 30, 2015
Q2 2015 1.58K Jun 30, 2015
Q1 2015 1.45K Mar 31, 2015
Q4 2014 997 Dec 31, 2014
Q3 2014 476 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.